Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Steadman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposureMichelle A Rudek, Cathy Y Chang, Kenneth Steadman, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Molecular Cancer Therapeutics|June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structureRobert W Robey, Suneet Shukla, Kenneth Steadman, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cellsJyoti Panicker, Zhijie Li, Christine McMahon, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Single nucleotide polymorphisms modify the transporter activity of ABCG2Kuniaki Morisaki, Robert W Robey, Csilla Ozvegy-Laczka, et al.
Frontiers in Cell and Developmental Biology|July 24, 2023
Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated regionKenneth Steadman, Sungyong You, Dustin V Srinivas, et al.
Experimental Hematology|February 17, 2009
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|February 3, 2005
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapyRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposureMichelle A Rudek, Cathy Y Chang, Kenneth Steadman, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Molecular Cancer Therapeutics|June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structureRobert W Robey, Suneet Shukla, Kenneth Steadman, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cellsJyoti Panicker, Zhijie Li, Christine McMahon, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Single nucleotide polymorphisms modify the transporter activity of ABCG2Kuniaki Morisaki, Robert W Robey, Csilla Ozvegy-Laczka, et al.
Frontiers in Cell and Developmental Biology|July 24, 2023
Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated regionKenneth Steadman, Sungyong You, Dustin V Srinivas, et al.
Experimental Hematology|February 17, 2009
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, et al.
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Pageof 2